This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

Evolocumab Benefits High-Risk Patients With Established Cardiovascular and Chronic Kidney Disease
News | Pharmaceuticals | October 31, 2018

October 31, 2018 — Amgen announced a new Repatha...

Rivaroxaban (Xeralto) is now cleared by the FDA with a new indication is for patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).
Technology | Antiplatelet and Anticoagulation Therapies | October 17, 2018

October 17, 2018 — The U.S. Food and Drug Administration (FDA) has cleared an additional indication for rivaroxaban...

Jardiance Improves Life Expectancy for Adults With Type 2 Diabetes and Cardiovascular Disease
News | Pharmaceuticals | October 11, 2018

October 11, 2018 — Novel results from the landmark EMPA-REG OUTCOME...

 Pulmonary artery denervation for CpcPH from the PADN-5 trial. #TCT2017

A series of procedural images of a pulmonary artery denervation for CpcPH from the PADN-5 trial.

News | Hypertension | October 04, 2018

October 4, 2018 — Pulmonary artery denervation (PADN) is associated with significant improvements in hemodynamic and...

Antithrombin Drug Ineffective in Heart Failure With Sinus Rhythm and Coronary Disease
News | Heart Failure | September 07, 2018

September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival,...

Thrombolytic Science Initiates Phase 2 Trial of Novel Ischemic Stroke Treatment Regimen
News | Antiplatelet and Anticoagulation Therapies | September 07, 2018

September 7, 2018 — A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science...

Tafamidis Improves Survival in Rare Heart Condition
News | Heart Failure | September 06, 2018

September 6, 2018 — Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart...

Effect of Daily Aspirin on First-Time Heart Attack and Stroke Risk Inconclusive
News | Pharmaceuticals | September 04, 2018

September 4, 2018 — The jury is still out on whether people at moderate risk of a first heart attack or stroke...

Blood Pressure and Cholesterol-lowering Drugs Continue to Improve Survival After a Decade
News | Pharmaceuticals | August 27, 2018

August 27, 2018 — Blood pressure and cholesterol-lowering...

Xarelto Associated With Reduced Hospital Time and Costs for Low-risk PE Patients
News | Pulmonary Embolism | June 29, 2018

June 29, 2018 — Results from the MERCURY PE...

AFib Patients Want More Information About Anticoagulation Reversal
News | Antiplatelet and Anticoagulation Therapies | June 27, 2018

June 27, 2018 — Results from a 902-person, five-country survey of people living with...

Overlay Init